Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rutten

Showing results (81-90 of 356) with videos related to

Pageof 36
Sort By:
Health Policy (Amsterdam, Netherlands)|June 7, 1995
Indirect costs of disease; an international comparisonL van Roijen, M A Koopmanschap, F F Rutten, et al.
The British Journal of Dermatology|October 9, 2002
The cost of atopic dermatitis in the Netherlands: an international comparisonP Verboom, L Hakkaart-Van, M Sturkenboom, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 11, 1995
[Adjustment to insulin of patients with type II diabetes mellitus in primary care; good results at low cost]A A van der Riet, P P Harteloh, F F Rutten, et al.
Pharmacoeconomics|December 8, 1997
An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's diseaseJ J Busschbach, W B Brouwer, A van der Donk, et al.
Journal of Pediatric Surgery|April 19, 2000
Cost-effectiveness of neonatal surgery: a reviewE A Stolk, H A Post, F F Rutten, et al.
Pharmacoeconomics|July 24, 2001
The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasisL Hakkaart-van Roijen, P Verboom, W K Redekop, et al.
Perceptual and Motor Skills|March 11, 2000
Factors to consider when designing phase III clinical trials involving economic evaluationsP J van Enckevort, E M TenVergert, J Kingma, et al.
International Journal of Technology Assessment in Health Care|January 1, 1996
Labor and health status in economic evaluation of health care. The Health and Labor QuestionnaireL van Roijen, M L Essink-Bot, M A Koopmanschap, et al.
Diseases of the Colon and Rectum|June 30, 1998
Cost-effectiveness of dynamic graciloplasty in patients with fecal incontinenceE M Adang, G L Engel, F F Rutten, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myelomaC A Uyl-de Groot, G J Ossenkoppele, A A van Riet, et al.
Pageof 36

Showing results (81-90 of 356) with videos related to

Sort By:
Pageof 36
Health Policy (Amsterdam, Netherlands)|June 7, 1995
Indirect costs of disease; an international comparisonL van Roijen, M A Koopmanschap, F F Rutten, et al.
The British Journal of Dermatology|October 9, 2002
The cost of atopic dermatitis in the Netherlands: an international comparisonP Verboom, L Hakkaart-Van, M Sturkenboom, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 11, 1995
[Adjustment to insulin of patients with type II diabetes mellitus in primary care; good results at low cost]A A van der Riet, P P Harteloh, F F Rutten, et al.
Pharmacoeconomics|December 8, 1997
An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's diseaseJ J Busschbach, W B Brouwer, A van der Donk, et al.
Journal of Pediatric Surgery|April 19, 2000
Cost-effectiveness of neonatal surgery: a reviewE A Stolk, H A Post, F F Rutten, et al.
Pharmacoeconomics|July 24, 2001
The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasisL Hakkaart-van Roijen, P Verboom, W K Redekop, et al.
Perceptual and Motor Skills|March 11, 2000
Factors to consider when designing phase III clinical trials involving economic evaluationsP J van Enckevort, E M TenVergert, J Kingma, et al.
International Journal of Technology Assessment in Health Care|January 1, 1996
Labor and health status in economic evaluation of health care. The Health and Labor QuestionnaireL van Roijen, M L Essink-Bot, M A Koopmanschap, et al.
Diseases of the Colon and Rectum|June 30, 1998
Cost-effectiveness of dynamic graciloplasty in patients with fecal incontinenceE M Adang, G L Engel, F F Rutten, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myelomaC A Uyl-de Groot, G J Ossenkoppele, A A van Riet, et al.
Pageof 36